Delivery Order SPE2DB20D3505-SPE2DB23FT7X2
- Not listed
- This federal contract award is for the procurement of Varenicline 1 mg tablets (56 count) by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,185.11, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is issued as a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Varenicline 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 7, 2024. The ceiling value of this award is $1,172.64. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of VARENICLINE 1 MG TABLET 56S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,010.85, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
- This federal contract award, valued at $1,736.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of 56 tablets of the medication Varenicline 1 mg. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Varenicline 1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,354.12 and an ultimate completion date of September 20, 2022. The contract is not designated as a set-aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of 56 count tablets of the medication varenicline, with a ceiling value of $1,269.11. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division, valued at $999,999,999 and running through...
- This federal contract award, valued at $3,130.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is for the delivery of Varenicline 1 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract has an award value of $2,880.05 and an ultimate completion date of January 21, 2025. The contract is a Firm Fixed Price Delivery Order, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside....
- This federal contract award, valued at $10,501.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of varenicline 1 mg tablets, a medication used to treat nicotine addiction. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued...
- This federal contract award is for the delivery of Varenicline 0.5 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $8,160.22, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is April 29, 2024. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT7X2Delivery Order
This federal contract award is for the delivery of Varenicline 1 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The award, valued at $2,033.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/1/23 |